BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

Xenometrix GmbH Pages on BioPortfolio:

BioPortfolio - Xenometrix GmbH
Xenometrix GmbH - BioPortfolio. ... BioNews Results for Xenometrix GmbH. • A novel solid phase technology for high-throughput gene synthesis. ...
http://www.bioportfolio.com/search/Xenometrix_GmbH.html...

BioPortfolio - Xenometrix Incorporated
Nineteen coded chemicals were tested in an international collaborative... 24th August, 2004, Xenometrix by Endotell GmbH, CH-4125 Allschwil, Switzerland. ...
http://www.bioportfolio.com/biocorporate/11091-Xenometrix_In...

BioPortfolio - the biotechnology, pharmaceutical, life science and ...
... New CEO at CEVEC Pharmaceuticals GmbH · Ablynx is awarded €1.8 million grant to explore novel methods for uses of Nanobodies® · Drug Patent Expirations ...
http://www.bioportfolio.com/...

Results from other life science and pharmaceutical sites:

BioPortfolio - Xenometrix GmbH
Xenometrix GmbH - BioPortfolio. ... BioNews Results for Xenometrix GmbH. • A novel solid phase technology for high-throughput gene synthesis. ...
http://www.bioportfolio.com/search/Xenometrix_GmbH.html...

Xenometrix
Xenometrix by Endotell GmbH.
http://www.xenometrix.ch/...

BioPortfolio - Xenometrix Incorporated
Nineteen coded chemicals were tested in an international collaborative... 24th August, 2004, Xenometrix by Endotell GmbH, CH-4125 Allschwil, Switzerland. ...
http://www.bioportfolio.com/biocorporate/11091-Xenometrix_In...

Comparison of pre-assay clean-up procedures for unveiling the ...
UFZ Centre for Environmental Research Leipzig-Hal e GmbH, Department of Effect- Directed Analysis. 2. Xenometrix by Endotel GmbH. Materials & Methods ...
http://www.xenometrix.ch/pdf/Poster%20Streck%20Montreal%2020...

Assessment of the performance of the Ames II assay...[Mutat Res ...
Xenometrix by Endotell GmbH, CH-4125 Allschwil, Switzerland. sf@xenometrix.ch. Nineteen coded chemicals were tested in an international collaborative study ...
http://www.ncbi.nlm.nih.gov/pubmed/15036131...

Technology evaluation: SAGE, Genzyme Molecular Oncology John Bartlett
Stoffel GmbH, NeuralStem BioPharmaceuticals Ltd, Celera. Genomics, National Cancer Institute, Xenometrix Inc. Status Discovery ...
http://www.biomedcentral.com/content/pdf/cd-398810.pdf...

BioSpace Life Sciences Company Profiles by Services and Suppliers
VivaCell Biotechnology GmbH · X-Ceptor Therapeutics, Inc. Xenometrix, Inc. York Nutritional Laboratories, Inc. About Biospace | Contact Us | Privacy ...
http://www.biospace.com/company_services_suppliers.aspx?Segm...

Sheet1
52, MorphoSys GmbH, 8270103, 15462886, Converted from DM (16044000) (29998000) ... 74, Xenometrix, 73000, 680000, Year ended June 30, 2000 ...
http://www.stanford.edu/class/siw198q/websites/genomics/R&D2...

Galapagos
Ltd), Verenigde Staten (BioFocus Inc, Compound Focus Inc, BioFocus DPI Inc, Xenometrix Inc),. Zwitserland (BioFocus DPI AG), Duitsland (DPI GmbH), ...
http://www.glpg.com/pdf/verslag_enkelvoudig2007.pdf...

Market Cap
55, MorphoSys GmbH (E), 418.40, 24.09, 118.60, 3.58, 1497.04, 86.19, 424.35 ... 77, Xenometrix, 0.31, 3.35, 1.05, Fiscal year ends June 01 - no hi lo data ...
http://www.stanford.edu/class/siw198q/websites/genomics/MktC...

Google Custom Search

Search
  

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo